Your browser is no longer supported. Please, upgrade your browser.
Codexis, Inc.
Index- P/E- EPS (ttm)-0.41 Insider Own0.80% Shs Outstand60.49M Perf Week-16.19%
Market Cap1.30B Forward P/E- EPS next Y-0.64 Insider Trans-16.65% Shs Float53.09M Perf Month-16.79%
Income-24.00M PEG- EPS next Q-0.20 Inst Own96.60% Short Float11.80% Perf Quarter-28.96%
Sales69.10M P/S18.85 EPS this Y-91.60% Inst Trans1.95% Short Ratio10.21 Perf Half Y46.17%
Book/sh2.81 P/B7.05 EPS next Y-4.90% ROA-14.80% Target Price27.50 Perf Year65.72%
Cash/sh2.28 P/C8.68 EPS next 5Y15.00% ROE-21.10% 52W Range10.28 - 29.56 Perf YTD-9.21%
Dividend- P/FCF- EPS past 5Y-16.00% ROI-14.30% 52W High-32.95% Beta1.27
Dividend %- Quick Ratio7.30 Sales past 5Y10.60% Gross Margin80.10% 52W Low92.80% ATR1.37
Employees181 Current Ratio7.40 Sales Q/Q12.30% Oper. Margin-34.60% RSI (14)33.71 Volatility6.79% 5.41%
OptionableYes Debt/Eq0.00 EPS Q/Q-498.40% Profit Margin-34.80% Rel Volume1.56 Prev Close20.36
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout- Avg Volume614.05K Price19.82
Recom1.60 SMA20-15.91% SMA50-11.68% SMA2007.40% Volume955,792 Change-2.65%
Apr-12-21Initiated Piper Sandler Overweight $32
Mar-01-21Initiated Stifel Buy $30
Feb-26-21Reiterated H.C. Wainwright Buy $21 → $26
Mar-10-20Initiated The Benchmark Company Buy
Jan-17-19Upgrade First Analysis Sec Neutral → Outperform $12 → $19
May-16-18Initiated Stephens Overweight $16
Oct-13-17Reiterated H.C. Wainwright Buy $8 → $8.50
May-31-17Initiated Jefferies Buy $8
Jan-26-17Downgrade First Analysis Sec Overweight → Equal-Weight $5.50
Jan-04-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16Initiated H.C. Wainwright Buy $6
May-06-21 06:20PM  
Apr-22-21 04:05PM  
Apr-05-21 03:10PM  
Mar-30-21 02:51AM  
Mar-01-21 10:14AM  
Feb-25-21 04:55PM  
Feb-18-21 04:05PM  
Feb-16-21 05:59AM  
Feb-13-21 02:19AM  
Feb-11-21 04:05PM  
Feb-09-21 04:05PM  
Feb-03-21 04:05PM  
Jan-13-21 07:00AM  
Jan-08-21 12:55AM  
Jan-05-21 07:00AM  
Dec-31-20 07:31PM  
Dec-30-20 02:50PM  
Dec-14-20 11:39AM  
Dec-08-20 12:44AM  
Dec-02-20 11:11PM  
Nov-24-20 05:02PM  
Nov-09-20 07:00AM  
Nov-07-20 08:38AM  
Nov-05-20 08:30PM  
Oct-29-20 07:00AM  
Sep-08-20 07:00AM  
Aug-11-20 08:33AM  
Aug-06-20 04:05PM  
Jul-30-20 07:00AM  
Jul-28-20 12:33PM  
Jun-23-20 07:00AM  
Jun-22-20 03:06PM  
Jun-16-20 04:05PM  
Jun-14-20 03:50PM  
Jun-01-20 04:05PM  
May-27-20 07:00AM  
May-22-20 07:31PM  
May-11-20 07:00AM  
May-09-20 01:30AM  
May-07-20 04:05PM  
May-06-20 04:05PM  
May-05-20 07:00AM  
Apr-30-20 07:00AM  
Apr-27-20 12:31PM  
Apr-07-20 08:37AM  
Mar-23-20 07:00AM  
Mar-13-20 01:57PM  
Mar-02-20 10:15AM  
Mar-01-20 07:19AM  
Feb-27-20 06:55PM  
Feb-25-20 07:00AM  
Feb-20-20 07:00AM  
Jan-31-20 07:52AM  
Jan-13-20 04:05PM  
Jan-10-20 07:00AM  
Jan-01-20 09:06AM  
Dec-24-19 07:24AM  
Dec-23-19 07:00AM  
Dec-16-19 06:10AM  
Dec-05-19 04:05PM  
Dec-02-19 12:32PM  
Nov-16-19 09:39PM  
Nov-06-19 09:00AM  
Nov-05-19 07:55PM  
Oct-29-19 07:00AM  
Oct-27-19 08:13PM  
Oct-26-19 09:13AM  
Oct-15-19 04:05PM  
Sep-26-19 08:00AM  
Sep-20-19 06:57AM  
Aug-29-19 07:11AM  
Aug-22-19 11:15PM  
Aug-09-19 01:32PM  
Aug-07-19 03:49PM  
Aug-06-19 07:35PM  
Jul-30-19 07:00AM  
Jun-27-19 03:01PM  
Jun-20-19 07:00AM  
Jun-10-19 12:06PM  
May-30-19 07:00AM  
May-16-19 09:34AM  
May-15-19 09:00AM  
May-14-19 04:05PM  
May-10-19 01:51AM  
May-09-19 10:07AM  
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KELLEY BERNARD JDirectorApr 21Sale22.642,50056,608206,136Apr 22 04:12 PM
Yang Patrick YDirectorApr 05Sale24.2710,000242,73283,716Apr 07 04:48 PM
WOLF DENNIS PDirectorMar 25Sale20.4410,000204,35141,129Mar 29 04:07 PM
KELLEY BERNARD JDirectorMar 08Option Exercise10.5120,000210,200228,636Mar 09 04:20 PM
KELLEY BERNARD JDirectorMar 08Sale18.7220,000374,350208,636Mar 09 04:20 PM
Dorgan Byron LDirectorJan 21Option Exercise10.6325,000265,750187,790Jan 21 07:29 PM
KELLEY BERNARD JDirectorJan 21Sale24.982,50062,439208,636Jan 21 07:30 PM
Dorgan Byron LDirectorJan 21Sale25.1725,000629,195162,790Jan 21 07:29 PM
Dorgan Byron LDirectorJan 20Option Exercise10.6325,000265,750187,790Jan 21 07:29 PM
Dorgan Byron LDirectorJan 20Sale26.7525,000668,658162,790Jan 21 07:29 PM
WOLF DENNIS PDirectorDec 21Sale19.9910,000199,87451,129Dec 22 04:08 PM
KELLEY BERNARD JDirectorOct 21Sale14.002,50035,007211,136Oct 23 04:04 PM
Dorgan Byron LDirectorOct 09Option Exercise10.6325,000265,750187,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 09Sale13.5425,000338,528162,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 08Option Exercise10.6325,000265,750187,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 08Sale13.4925,000337,315162,790Oct 13 04:04 PM
WOLF DENNIS PDirectorSep 24Sale11.6810,000116,84561,129Sep 28 04:03 PM
KELLEY BERNARD JDirectorJul 21Sale12.792,50031,965213,636Jul 23 04:16 PM
WOLF DENNIS PDirectorJun 25Sale10.9710,000109,69471,129Jun 26 04:18 PM
BARUCH THOMAS RDirectorJun 12Sale10.614,94752,46433,093Jun 16 04:03 PM